Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children.
Haemophilus influenza
children
Hia
ST62
meningitis
Journal
Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049
Informations de publication
Date de publication:
31 Dec 2020
31 Dec 2020
Historique:
received:
13
08
2019
accepted:
02
12
2019
pubmed:
21
12
2019
medline:
19
8
2021
entrez:
21
12
2019
Statut:
ppublish
Résumé
Following widespread use of the Haemophilus influenzae serotype b (Hib) vaccine, H. influenzae serotype a (Hia) has emerged as an important pathogen in children in some regions. We describe the clinical features and molecular epidemiology of invasive Hia disease in children in Utah over an 11-year period. We identified cases of invasive Hia disease, defined as detection of Hia from a normally sterile site, in children aged <18 years from Utah between 2007 and 2017. Medical records were reviewed to determine demographic characteristics and clinical outcomes. Available Hia isolates were genotyped using multilocus sequence typing, and phylogenetic division was determined using sodC polymerase chain reaction. Presence of the putative virulence-associated IS1016-bexA duplication-deletion was evaluated. We identified 51 children with invasive Hia. The average annual incidence was 1.7 cases per 100 000 children aged <5 years; 4.8 cases per 100 000 children aged <1 year. The median age was 11.3 months. The most common clinical presentation was meningitis (53%), followed by pneumonia (14%) and septic arthritis (14%). Twenty-two children (43%) required admission to an intensive care unit; 1 died. Sequence type (ST) 62, phylogenetic division II isolates caused 75% (21/28) of disease. No isolates contained the virulence-associated IS1016-bexA duplication-deletion. Hia is a significant cause of severe invasive bacterial infection in Utah. The majority of infections were caused by ST62 isolates, a phylogenetic division II Hia type that lacks the IS1016-bexA duplication-deletion. Hia ST62 has not been commonly reported elsewhere, suggesting a unique molecular epidemiology in our population.
Sections du résumé
BACKGROUND
BACKGROUND
Following widespread use of the Haemophilus influenzae serotype b (Hib) vaccine, H. influenzae serotype a (Hia) has emerged as an important pathogen in children in some regions. We describe the clinical features and molecular epidemiology of invasive Hia disease in children in Utah over an 11-year period.
METHODS
METHODS
We identified cases of invasive Hia disease, defined as detection of Hia from a normally sterile site, in children aged <18 years from Utah between 2007 and 2017. Medical records were reviewed to determine demographic characteristics and clinical outcomes. Available Hia isolates were genotyped using multilocus sequence typing, and phylogenetic division was determined using sodC polymerase chain reaction. Presence of the putative virulence-associated IS1016-bexA duplication-deletion was evaluated.
RESULTS
RESULTS
We identified 51 children with invasive Hia. The average annual incidence was 1.7 cases per 100 000 children aged <5 years; 4.8 cases per 100 000 children aged <1 year. The median age was 11.3 months. The most common clinical presentation was meningitis (53%), followed by pneumonia (14%) and septic arthritis (14%). Twenty-two children (43%) required admission to an intensive care unit; 1 died. Sequence type (ST) 62, phylogenetic division II isolates caused 75% (21/28) of disease. No isolates contained the virulence-associated IS1016-bexA duplication-deletion.
CONCLUSIONS
CONCLUSIONS
Hia is a significant cause of severe invasive bacterial infection in Utah. The majority of infections were caused by ST62 isolates, a phylogenetic division II Hia type that lacks the IS1016-bexA duplication-deletion. Hia ST62 has not been commonly reported elsewhere, suggesting a unique molecular epidemiology in our population.
Identifiants
pubmed: 31858115
pii: 5681536
doi: 10.1093/jpids/piz088
pmc: PMC10147389
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
650-655Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : K12 HD047349
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Vaccine. 2017 Jul 24;35(33):4270-4275
pubmed: 28666758
BMC Infect Dis. 2018 Nov 22;18(1):592
pubmed: 30466407
Microb Pathog. 1986 Oct;1(5):465-73
pubmed: 3509884
Lancet Infect Dis. 2014 Jan;14(1):70-82
pubmed: 24268829
Proc Natl Acad Sci U S A. 1988 Oct;85(20):7758-62
pubmed: 2902639
J Med Microbiol. 1995 Aug;43(2):120-4
pubmed: 7629851
J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):261-264
pubmed: 29579288
Clin Infect Dis. 2010 Apr 1;50(7):e41-6
pubmed: 20178414
Pediatr Infect Dis J. 2007 Nov;26(11):1025-31
pubmed: 17984810
Can J Microbiol. 2013 May;59(5):362-4
pubmed: 23647351
Emerg Infect Dis. 2011 Sep;17(9):1645-50
pubmed: 21888789
J Bacteriol. 1988 Feb;170(2):859-64
pubmed: 2828329
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Clin Infect Dis. 2009 Oct 15;49(8):1240-3
pubmed: 19761408
Pediatr Infect Dis J. 2018 Apr;37(4):298-303
pubmed: 29189672
Clin Infect Dis. 2005 Mar 15;40(6):823-30
pubmed: 15736015
J Med Microbiol. 2011 Mar;60(Pt 3):384-390
pubmed: 21148281
Lancet. 2009 Sep 12;374(9693):903-11
pubmed: 19748399
J Infect Dis. 1993 Jul;168(1):172-6
pubmed: 8515106
J Infect Dis. 1981 Apr;143(4):517-24
pubmed: 6972419
Emerg Infect Dis. 2013 Jun;19(6):932-7
pubmed: 23735653
Clin Infect Dis. 2005 Dec 1;41(11):e97-103
pubmed: 16267724
Microb Pathog. 1989 Sep;7(3):225-35
pubmed: 2615636
Can J Microbiol. 2007 Oct;53(10):1191-4
pubmed: 18026212
Pediatr Infect Dis J. 1987 Aug;6(8):779-82
pubmed: 3313240
Clin Microbiol Rev. 2000 Apr;13(2):302-17
pubmed: 10756001
J Infect Dis. 2010 Nov 15;202(10):1577-84
pubmed: 20932170
J Exp Med. 1931 Mar 31;53(4):471-92
pubmed: 19869858
Infect Immun. 2003 Dec;71(12):7202-7
pubmed: 14638817
Clin Infect Dis. 2018 Aug 31;67(6):881-889
pubmed: 29509834
Int J Circumpolar Health. 2013 Aug 05;72:
pubmed: 25152869
Pediatrics. 2001 Jul;108(1):E18
pubmed: 11433097
Mem Inst Oswaldo Cruz. 2017 Mar;112(3):196-202
pubmed: 28225904
J Clin Microbiol. 2003 Apr;41(4):1623-36
pubmed: 12682154
Int J Infect Dis. 2017 Apr;57:104-107
pubmed: 28232014
J Infect Dis. 1977 Jan;135(1):34-41
pubmed: 299866